Exploiting evolutionary steering to induce collateral drug sensitivity in cancer

Drug resistance mediated by clonal evolution is arguably the biggest problem in cancer therapy today. However, evolving resistance to one drug may come at a cost of decreased fecundity or increased sensitivity to another drug. These evolutionary trade-offs can be exploited using ‘evolutionary steeri...

Descripción completa

Detalles Bibliográficos
Autores principales: Acar, Ahmet, Nichol, Daniel, Fernandez-Mateos, Javier, Cresswell, George D., Barozzi, Iros, Hong, Sung Pil, Trahearn, Nicholas, Spiteri, Inmaculada, Stubbs, Mark, Burke, Rosemary, Stewart, Adam, Caravagna, Giulio, Werner, Benjamin, Vlachogiannis, Georgios, Maley, Carlo C., Magnani, Luca, Valeri, Nicola, Banerji, Udai, Sottoriva, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174377/
https://www.ncbi.nlm.nih.gov/pubmed/32317663
http://dx.doi.org/10.1038/s41467-020-15596-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174377/
https://www.ncbi.nlm.nih.gov/pubmed/32317663
http://dx.doi.org/10.1038/s41467-020-15596-z

Ejemplares similares